Avalyn Pharma Inc. Shares Outstanding
Avalyn Pharma Inc. (AVLN) had Shares Outstanding of 44.33 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-12
- 2026-06-30: Shares outstanding (split-adjusted) 44.33M shares; Shares authorized (split-adjusted) 700.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 1.23M shares; Shares authorized (split-adjusted) 585.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 1.23M shares; Shares authorized (split-adjusted) 575.00M shares.
- 2025-04-30: Shares outstanding (split-adjusted) (m); Shares authorized (split-adjusted) 575.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 44.33M shares 10-Q · filed 2026-08-12 | 700.00M shares 10-Q · filed 2026-08-12 |
| 2026-03-31 | 1.23M shares 10-Q · filed 2026-06-03 | 585.00M shares 10-Q · filed 2026-06-03 |
| 2025-12-31 | 1.23M shares 10-Q · filed 2026-08-12 | 575.00M shares 10-Q · filed 2026-08-12 |
| 2025-04-30 | (m) | 575.00M shares 10-Q · filed 2026-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B |